Rapt Therapeutics Inc (NASDAQ:RAPT)
| 17.19 BATS BZX Real-Time Price As of 3:57pm ET |  -0.02 / -0.12%Today’s Change | 15.59 Today|||52-Week Range 31.45 | -13.18% Year-to-Date |
Latest RAPT News | Press Releases
No recent news for Rapt Therapeutics Inc.
Today’s Trading
| Previous close | 17.21 |
| Today’s open | 17.27 |
| Day’s range | 16.11 - 17.42 |
| Volume | 11,638 |
| Average volume (3 months) | 283,386 |
| Market cap | $591.3M |
Data as of 3:57pm ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | -1.97% |
| Earnings growth (this year) | -22.76% |
| Earnings growth (next 5 years) | +23.10% |
| Revenue growth (last year) | -59.95% |
| P/E ratio | NM |
| Price/Sales | 421.94 |
| Price/Book | 2.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TVTXTravere Therapeutics... | +0.15 | +1.91% |
| CDMOAvid Bioservices Inc | +0.09 | +0.94% |
| ALECAlector Inc | +0.10 | +1.38% |
| ALPNAlpine Immune Scienc... | +0.43 | +3.73% |
Data as of 3:57pm ET, 09/25/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.80 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$83.8M |
| Net profit margin | -5,490.37% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
